|
1
|
Drexler KE: Nanosystems: Molecular
Machinery, Manufacturing, and Computation. John Wiley & Sons,
New York, NY, 1989.
|
|
2
|
Drexler KE: Engines of Creation: The
Coming Era of Nanotechnology. Anchor Books, Doubleday, 1986.
|
|
3
|
Belkin A, Hubler A and Bezryadin A:
Self-assembled wiggling nano-structures and the principle of
maximum entropy production. Sci Rep. 5(8323)2015.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Buzea C, Pacheco II and Robbie K:
Nanomaterials and nanoparticles: Sources and toxicity.
Biointerphases. 2:MR17–MR71. 2007.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kroto HW, Heath O Jr, O'Brien SC, Curl RF
and Smalley RE: Buckminsterfullerene. This Week's Citation Classic.
Nature. 318:162–163. 1985.
|
|
6
|
Allhoff F, Patrick L and Daniel M: What is
Nanotechnology and Why Does it Matter? From Science to Ethics. John
Wiley & Sons, pp3-5, 2010.
|
|
7
|
Mashaghi S, Jadidi T, Koenderink G and
Mashaghi A: Lipid nanotechnology. Int J Mol Sci. 14:4242–4282.
2013.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Farokhzad OC and Langer R: Nanomedicine:
Developing smarter therapeutic and diagnostic modalities. Adv Drug
Deliv Rev. 58:1456–1459. 2006.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Filipponi L and Nicolau DV: Cell
Patterning. Wiley Encyclopedia of Biomedical Engineering. John
Wiley & Sons, 2006.
|
|
10
|
Lombardo D, Kiselev MA and Caccamo MT:
Smart Nanoparticles for Drug Delivery Application: Development of
Versatile Nanocarrier Platforms in Biotechnology and Nanomedicine.
J Nanomater. 12:1–26. 2019.
|
|
11
|
Katsuki S, Matoba T, Koga JI, Nakano K and
Egashira K: Anti-inflammatory Nanomedicine for Cardiovascular
Disease. Front Cardiovasc Med. 4(87)2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Morgan MT, Carnahan MA, Finkelstein S,
Prata CA, Degoricija L, Lee SJ and Grinstaff MW: Dendritic
supramolecular assemblies for drug delivery. Chem Commun (Camb).
97:4309–4311. 2005.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Tiriveedhi V, Kitchens KM, Nevels KJ,
Ghandehari H and Butko P: Kinetic analysis of the interaction
between poly(amidoamine) dendrimers and model lipid membranes.
Biochim Biophys Acta. 1808:209–218. 2011.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Palmerston Mendes L, Pan J and Torchilin
VP: Dendrimers as nanocarriers for nucleic acid and drug delivery
in cancer therapy. Molecules. 22(1401)2017.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Kukowska-Latallo JF, Bielinska AU, Johnson
J, Spindler R, Tomalia DA and Baker JR Jr: Efficient transfer of
genetic material into mammalian cells using Starburst
polyamidoamine dendrimers. Proc Natl Acad Sci USA. 93:4897–4902.
1996.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Svenson S and Tomalia DA: Dendrimers in
biomedical applications - reflections on the field. Adv Drug Deliv
Rev. 57:2106–2129. 2005.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Nune SK, Gunda P, Thallapally PK, Lin YY,
Forrest ML and Berkland CJ: Nanoparticles for biomedical imaging.
Expert Opin Drug Deliv. 6:1175–1194. 2009.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Shi Kam NW, Jessop TC, Wender PA and Dai
H: Nanotube molecular transporters: Internalization of carbon
nanotube-protein conjugates into Mammalian cells. J Am Chem Soc.
126:6850–6851. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Pantarotto D, Briand JP, Prato M and
Bianco A: Translocation of bioactive peptides across cell membranes
by carbon nanotubes. Chem Commun (Camb). 7:16–17. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
20
|
Dai HJ, Hafner JH, Rinzler AG, Colbert DT
and Smalley RE: Nanotubes as nanoprobes in scanning probe
microscopy. Nature. 384:147–150. 1996.
|
|
21
|
Acharya S and Sahoo SK: PLGA nanoparticles
containing various anticancer agents and tumour delivery by EPR
effect. Adv Drug Deliv Rev. 63:170–183. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mulder WJ, Strijkers GJ, van Tilborg GA,
Cormode DP, Fayad ZA and Nicolay K: Nanoparticulate assemblies of
amphiphiles and diagnostically active materials for multimodality
imaging. Acc Chem Res. 42:904–914. 2009.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Probst CE, Zrazhevskiy P, Bagalkot V and
Gao X: Quantum dots as a platform for nanoparticle drug delivery
vehicle design. Adv Drug Deliv Rev. 65:703–718. 2013.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Medina C, Santos-Martinez MJ, Radomski A,
Corrigan OI and Radomski MW: Nanoparticles: Pharmacological and
toxicological significance. Br J Pharmacol. 150:552–558.
2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Ratner BD and Bryant SJ: Biomaterials:
Where we have been and where we are going. Annu Rev Biomed Eng.
6:41–75. 2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Sakiyama-Elbert SE and Hubbell JA:
Functional biomaterials: Design of novel biomaterials. Annu Rev
Mater Res. 31:183–201. 2001.
|
|
27
|
Wickline SA and Lanza GM: Nanotechnology
for molecular imaging and targeted therapy. Circulation.
107:1092–1095. 2003.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lanone S and Boczkowski J: Biomedical
applications and potential health risks of nanomaterials: Molecular
mechanisms. Curr Mol Med. 6:651–663. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Loo C, Lin A, Hirsch L, Lee MH, Barton J,
Halas N, West J and Drezek R: Nanoshell-enabled photonics-based
imaging and therapy of cancer. Technol Cancer Res Treat. 3:33–40.
2004.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Choi MR, Stanton-Maxey KJ, Stanley JK,
Levin CS, Bardhan R, Akin D, Badve S, Sturgis J, Robinson JP,
Bashir R, et al: A cellular Trojan Horse for delivery of
therapeutic nanoparticles into tumors. Nano Lett. 7:3759–3765.
2007.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Abbasi A, Park K, Bose A and Bothun GD:
Near-Infrared Responsive Gold-Layersome Nanoshells. Langmuir.
33:5321–5327. 2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Helm L: Optimization of gadolinium-based
MRI contrast agents for high magnetic-field applications. Future
Med Chem. 2:385–396. 2010.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Vo-Dinh T and Cullum B: Biosensors and
biochips: Advances in biological and medical diagnostics. Fresenius
J Anal Chem. 366:540–551. 2000.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Silva GA: Neuroscience nanotechnology:
Progress, opportunities and challenges. Nat Rev Neurosci. 7:65–74.
2006.PubMed/NCBI View
Article : Google Scholar
|
|
35
|
Yan Z, Bin Y and Deng YH: Take the
initiative to drug-loaded liposomes prepared by vincristine sulfate
and the determination of encapsulation efficiency. Chung Kuo Yao
Hsueh Tsa Chih. 10(1559)2005.
|
|
36
|
Ochekpe NA, Olorunfemi PO and Ngwuluka NC:
Nanotechnology and drug delivery part 1: Background and
applications. Trop J Pharm Res. 8:265–274. 2009.
|
|
37
|
Zalipsky S: Polyethylene glycol-lipid
conjugates. In: Stealth Liposomes. CRC Press, Boca Raton, pp93-102,
1995.
|
|
38
|
Jain N, Jain R, Thakur N, Gupta BP and
Jain DK: Nanotechnology: A Safe and effective drug delivery system.
Asian J Pharm Clin Res. 3:159–165. 2010.
|
|
39
|
Kakade T, Kadam V, Dhanavade K and
Salunkhe V: A review on pharmaceutical nanotechnology: Dendrimers.
World J Pharm Pharm Sci. 2:4815–4830. 2013.
|
|
40
|
Tibbals HF: Medical Nanotechnology and
Nanomedicine. CRC Press, Taylor and Francis Group 31, 2011.
|
|
41
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2013. CA Cancer J Clin. 63:11–30. 2013.PubMed/NCBI View Article : Google Scholar
|
|
42
|
van Vlerken LE, Vyas TK and Amiji MM:
Poly(ethylene glycol)-modified nanocarriers for tumor-targeted and
intracellular delivery. Pharm Res. 24:1405–1414. 2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Biswas AK, Islam R, Choudhury ZS, Mostafa
A and Kadir MF: Nanotechnology based approaches in cancer
therapeutics. Adv Nat Sci Nanosci Nanotechnol. 5:2043–6262.
2004.
|
|
44
|
Gupta P, Vermani K and Garg S: Hydrogels:
From controlled release to pH-responsive drug delivery. Drug Discov
Today. 7:569–579. 2002.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Montero AJ, Adams B, Diaz-Montero CM and
Glück S: Nab-paclitaxel in the treatment of metastatic breast
cancer: A comprehensive review. Expert Rev Clin Pharmacol.
4:329–334. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Tsurutani J, Kuroi K, Iwasa T, Miyazaki M,
Nishina S, Makimura C, Tanizaki J, Okamoto K, Yamashita T, Aruga T,
et al: Phase I study of weekly nab-paclitaxel combined with S-1 in
patients with human epidermal growth factor receptor type
2-negative metastatic breast cancer. Cancer Sci. 106:734–739.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
McGill HC Jr, McMahan CA and Gidding SS:
Preventing heart disease in the 21st century: Implications of the
Pathobiological Determinants of Atherosclerosis in Youth (PDAY)
study. Circulation. 117:1216–1227. 2008.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Das A, Mukherjee P, Singla SK, Guturu P,
Frost MC, Mukhopadhyay D, Shah VH and Patra CR: Fabrication and
characterization of an inorganic gold and silica nanoparticle
mediated drug delivery system for nitric oxide. Nanotechnology.
21(305102)2010.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Deshpande D, Kethireddy S, Janero DR and
Amiji MM: Therapeutic efficacy of an ω-3-fatty acidcontaining 17-β
estradiol nano-delivery system against experimental
atherosclerosis. PLoS One. 11(e0147337)2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Wu T, Chen X, Wang Y, Xiao H, Peng Y, Lin
L, Xia W, Long M, Tao J and Shuai X: Aortic plaque-targeted
andrographolide delivery with oxidation-sensitive micelle
effectively treats atherosclerosis via simultaneous ROS capture and
anti-inflammation. Nanomedicine (Lond). 14:2215–2226.
2018.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Bulbake U, Doppalapudi S, Kommineni N and
Khan W: Liposomal formulations in clinical use: An updated review.
Pharmaceutics. 9(12)2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Zhang N, Li C, Zhou D, Ding C, Jin Y, Tian
Q, Meng X, Pu K and Zhu Y: Cyclic RGD functionalized liposomes
encapsulating urokinase for thrombolysis. Acta Biomater.
70:227–236. 2018.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Najlah M, Freeman S, Attwood D and
D'Emanuele A: In vitro evaluation of dendrimer prodrugs for oral
drug delivery. Int J Pharm. 336:183–190. 2007.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Korin N, Gounis MJ, Wakhloo AK and Ingber
DE: Targeted drug delivery to flow-obstructed blood vessels using
mechanically activated nanotherapeutics. JAMA Neurol. 72:119–122.
2015.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Sahaym U and Norton M: Advances in the
application of nanotechnology in enabling a hydrogen economy. J
Mater Sci. 43:5395–5429. 2008.
|
|
56
|
Rickerby DG and Morrison M: Nanotechnology
and the environment: A European perspective. Sci Technol Adv Mater.
8:19–24. 2007.
|
|
57
|
Hoshyar N, Gray S, Han H and Bao G: The
effect of nanoparticle size on in vivo pharmacokinetics and
cellular interaction. Nanomedicine (Lond). 11:673–692.
2016.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Lee JM, Yoon TJ and Cho YS: Recent
developments in nanoparticle-based siRNA delivery for cancer
therapy. BioMed Res Int. 2013(782041)2013.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Asmatulu R and Asmatulu E: Importance of
recycling education: A curriculum development at Wichita State
University. J Mater Cycles Waste Manag. 14:1–8. 2011.
|
|
60
|
Narayan RJ, Kumta PN, Sfeir C, Lee DH,
Choi D and Olton D: Nanostructured ceramics in medical devices:
Applications and prospects. JOM. 56:38–43. 2004.
|
|
61
|
Byrne JD and Baugh JA: The significance of
nanoparticles in particle-induced pulmonary fibrosis. Mcgill J Med.
11:43–50. 2008.PubMed/NCBI
|
|
62
|
Hubler A and Osuagwu O: Digital quantum
batteries: Energy and information storage in nanovacuum tube
arrays. Complexity. 15:48–55. 2010.
|
|
63
|
Shinn E, Hübler A, Lyon D, Perdekamp M,
Bezryadin A and Belkin A: Nuclear energy conversion with stacks of
graphene nanocapacitors. Complexity. 18:24–27. 2012.
|
|
64
|
Kurtoglu ME, Longenbach T, Reddington P
and Gogotsi Y: Effect of calcination temperature and environment on
photocatalytic and mechanical properties of ultrathin sol-gel
titanium dioxide films. J Am Ceram Soc. 94:1101–1108. 2011.
|
|
65
|
Prencipe G, Tabakman SM, Welsher K, Liu Z,
Goodwin AP, Zhang L, Henry J and Dai H: PEG branched polymer for
functionalization of nanomaterials with ultralong blood
circulation. J Am Chem Soc. 131:4783–4787. 2009.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Swanson SD, Kukowska-Latallo JF, Patri AK,
Chen C, Ge S, Cao Z, Kotlyar A, East AT and Baker JR: Targeted
gadolinium-loaded dendrimer nanoparticles for tumor-specific
magnetic resonance contrast enhancement. Int J Nanomedicine.
3:201–210. 2008.PubMed/NCBI
|
|
67
|
Waters EA and Wickline SA: Contrast agents
for MRI. Basic Res Cardiol. 103:114–121. 2008.PubMed/NCBI View Article : Google Scholar
|
|
68
|
Smith AM, Duan H, Mohs AM and Nie S:
Bioconjugated quantum dots for in vivo molecular and cellular
imaging. Adv Drug Deliv Rev. 60:1226–1240. 2008.PubMed/NCBI View Article : Google Scholar
|
|
69
|
Wunderbaldinger P, Josephson L, Bremer C,
Moore A and Weissleder R: Detection of lymph node metastases by
contrast-enhanced MRI in an experimental model. Magn Reson Med.
47:292–297. 2002.PubMed/NCBI View Article : Google Scholar
|
|
70
|
Thorek DL and Tsourkas A: Size, charge and
concentration dependent uptake of iron oxide particles by
non-phagocytic cells. Biomaterials. 29:3583–3590. 2008.PubMed/NCBI View Article : Google Scholar
|
|
71
|
Nie L, Liu F, Ma P and Xiao X:
Applications of gold nanoparticles in optical biosensors. J Biomed
Nanotechnol. 10:2700–2721. 2014.PubMed/NCBI View Article : Google Scholar
|
|
72
|
Daraee H, Eatemadi A, Abbasi E, Fekri Aval
S, Kouhi M and Akbarzadeh A: Application of gold nanoparticles in
biomedical and drug delivery. Artif Cells Nanomed Biotechnol.
44:410–422. 2016.PubMed/NCBI View Article : Google Scholar
|
|
73
|
Cole LE, Ross RD, Tilley JM, Vargo-Gogola
T and Roeder RK: Gold nanoparticles as contrast agents in x-ray
imaging and computed tomography. Nanomedicine (Lond). 10:321–341.
2015.PubMed/NCBI View Article : Google Scholar
|
|
74
|
Hwang S, Nam J, Jung S, Song J, Doh H and
Kim S: Gold nanoparticle-mediated photothermal therapy: Current
status and future perspective. Nanomedicine (Lond). 9:2003–2022.
2014.PubMed/NCBI View Article : Google Scholar
|
|
75
|
Park JA, Lee JJ, Jung JC, Yu DY, Oh C, Ha
S, Kim TJ and Chang Y: Gd-DOTA conjugate of RGD as a potential
tumor-targeting MRI contrast agent. ChemBioChem. 9:2811–2813.
2008.PubMed/NCBI View Article : Google Scholar
|
|
76
|
Zhang W, Yong D, Huang J, Yu J, Liu S and
Fan MX: Fabrication of polymer-gadolinium (III) complex nanomicelle
from poly(ethylene glycol)-polysuccinimide conjugate and
diethylenetriaminetetraacetic acid-gadolinium as magnetic resonance
imaging contrast agents. J Appl Polym Sci. 120:2596–2605. 2011.
|
|
77
|
Karfeld-Sulzer LS, Waters EA, Davis NE,
Meade TJ and Barron AE: Multivalent protein polymer MRI contrast
agents: Controlling relaxivity via modulation of amino acid
sequence. Biomacromolecules. 11:1429–1436. 2010.PubMed/NCBI View Article : Google Scholar
|
|
78
|
Kamaly N and Miller AD: Paramagnetic
liposome nanoparticles for cellular and tumour imaging. Int J Mol
Sci. 11:1759–1776. 2010.PubMed/NCBI View Article : Google Scholar
|
|
79
|
Na HB, Song IC and Hyeon T: Inorganic
Nanoparticles for MRI Contrast Agents. Adv Mater. 21:2133–2148.
2019.
|
|
80
|
Shao YZ, Liu LZ, Song SQ, Cao RH, Liu H,
Cui CY, Li X, Bie MJ and Li L: A novel one-step synthesis of
Gd3+-incorporated mesoporous SiO2
nanoparticles for use as an efficient MRI contrast agent. Contrast
Media Mol Imaging. 6:110–118. 2011.PubMed/NCBI View Article : Google Scholar
|
|
81
|
Bobo D, Robinson KJ, Islam J, Thurecht KJ
and Corrie SR: Nanoparticle-based medicines: A review of
FDA-approved materials and clinical trials to date. Pharm Res.
33:2373–2387. 2016.PubMed/NCBI View Article : Google Scholar
|
|
82
|
Qiao R, Yang C and Gao M:
Superparamagnetic iron oxide nanoparticles: From preparations to in
vivo MRI applications. J Mater Chem. 19:6274–6293. 2009.
|
|
83
|
Teja AS and Koh P: Synthesis, properties,
and applications of magnetic iron oxide nanoparticles. Prog Cryst
Growth Charact Mater. 55:22–45. 2009.
|
|
84
|
Murbe J, Rechtenbach A and Topfer J:
Synthesis and physical characterisation of magnetite nanoparticles
for biomedical applications. Mater Chem Phys. 110:426–433.
2008.
|
|
85
|
Sun C, Lee JS and Zhang M: Magnetic
nanoparticles in MR imaging and drug delivery. Adv Drug Deliv Rev.
60:1252–1265. 2008.PubMed/NCBI View Article : Google Scholar
|
|
86
|
Hong J, Gong P, Xu D, Sun H and Yao S:
Synthesis and characterisation of carboxyl functionalised magnetic
nanogel via ‘green’ photochemical method. J Appl Polym Sci.
105:1882–1887. 2007.
|
|
87
|
Gupta AK and Gupta M: Synthesis and
surface engineering of iron oxide nanoparticles for biomedical
applications. Biomaterials. 26:3995–4021. 2005.PubMed/NCBI View Article : Google Scholar
|
|
88
|
Rabin O, Manuel Perez J, Grimm J,
Wojtkiewicz G and Weissleder R: An X-ray computed tomography
imaging agent based on long-circulating bismuth sulphide
nanoparticles. Nat Mater. 5:118–122. 2006.PubMed/NCBI View Article : Google Scholar
|
|
89
|
Hahn MA, Singh AK, Sharma P, Brown SC and
Moudgil BM: Nanoparticles as contrast agents for in-vivo
bioimaging: Current status and future perspectives. Anal Bioanal
Chem. 399:3–27. 2011.PubMed/NCBI View Article : Google Scholar
|
|
90
|
Elrod DB, Partha R, Danila D, Casscells SW
and Conyers JL: An iodinated liposomal computed tomographic
contrast agent prepared from a diiodophosphatidylcholine lipid.
Nanomedicine (Lond). 5:42–45. 2009.PubMed/NCBI View Article : Google Scholar
|
|
91
|
Kweon S, Lee HJ, Hyung WJ, Suh J, Lim JS
and Lim SJ: Liposomes coloaded with iopamidol/lipiodol as a
RES-targeted contrast agent for computed tomography imaging. Pharm
Res. 27:1408–1415. 2010.PubMed/NCBI View Article : Google Scholar
|
|
92
|
Zheng J, Allen C, Serra S, Vines D,
Charron M and Jaffray DA: Liposome contrast agent for CT-based
detection and localization of neoplastic and inflammatory lesions
in rabbits: Validation with FDG-PET and histology. Contrast Media
Mol Imaging. 5:147–154. 2010.PubMed/NCBI View Article : Google Scholar
|
|
93
|
Chrastina A and Schnitzer JE: Iodine-125
radiolabeling of silver nanoparticles for in vivo SPECT imaging.
Int J Nanomedicine. 5:653–659. 2010.PubMed/NCBI View Article : Google Scholar
|
|
94
|
Van Herck JL, De Meyer GR, Martinet W,
Salgado RA, Shivalkar B, De Mondt R, Van De Ven H, Ludwig A, Van
Der Veken P, Van Vaeck L, et al: Multi-slice computed tomography
with N1177 identifies ruptured atherosclerotic plaques in rabbits.
Basic Res Cardiol. 105:51–59. 2010.PubMed/NCBI View Article : Google Scholar
|
|
95
|
Aillon KL, El-Gendy N, Dennis C, Norenberg
JP, McDonald J and Berkland C: Iodinated NanoClusters as an inhaled
computed tomography contrast agent for lung visualization. Mol
Pharm. 7:1274–1282. 2010.PubMed/NCBI View Article : Google Scholar
|
|
96
|
Hainfeld JF, Slatkin DN, Focella TM and
Smilowitz HM: Gold nanoparticles: A new X-ray contrast agent. Br J
Radiol. 79:248–253. 2006.PubMed/NCBI View Article : Google Scholar
|
|
97
|
Kim D, Park S, Lee JH, Jeong YY and Jon S:
Antibiofouling polymer-coated gold nanoparticles as a contrast
agent for in vivo X-ray computed tomography imaging. J Am Chem Soc.
129:7661–7665. 2007.PubMed/NCBI View Article : Google Scholar
|
|
98
|
Pan J, Wang Y and Feng SS: Formulation,
characterization, and in vitro evaluation of quantum dots loaded in
poly(lactide)-vitamin E TPGS nanoparticles for cellular and
molecular imaging. Biotechnol Bioeng. 101:622–633. 2008.PubMed/NCBI View Article : Google Scholar
|
|
99
|
Yang L, Mao H, Wang YA, Cao Z, Peng X,
Wang X, Duan H, Ni C, Yuan Q, Adams G, et al: Single chain
epidermal growth factor receptor antibody conjugated nanoparticles
for in vivo tumor targeting and imaging. Small. 5:235–243.
2009.PubMed/NCBI View Article : Google Scholar
|
|
100
|
Ballou B, Ernst LA and Waggoner AS:
Fluorescence imaging of tumors in vivo. Curr Med Chem. 12:795–805.
2005.PubMed/NCBI View Article : Google Scholar
|
|
101
|
Ballou B, Ernst LA, Andreko S, Harper T,
Fitzpatrick JA, Waggoner AS and Bruchez MP: Sentinel lymph node
imaging using quantum dots in mouse tumor models. Bioconjug Chem.
18:389–396. 2007.PubMed/NCBI View Article : Google Scholar
|
|
102
|
Serp P, Corrias M and Kalck P: Carbon
nanotubes and nanofibers in catalysis. Appl Catal. 253:337–358.
2003.
|
|
103
|
Ghosh M, Singh AT, Xu W, Sulchek T, Gordon
LI and Ryan RO: Curcumin nanodisks: Formulation and
characterization. Nanomedicine (Lond). 7:162–167. 2011.PubMed/NCBI View Article : Google Scholar
|
|
104
|
Singh P: Impacts of nanotechnology on
environmental (Review). Int Arch App Sci Technol. 9:14–16.
2018.
|
|
105
|
Chandarana M, Curtis A and Hoskins C: The
use of nanotechnology in cardiovascular disease. Appl Nanosci.
8:1607–1619. 2018.
|
|
106
|
Dreher KL: Health and environmental impact
of nanotechnology: Toxicological assessment of manufactured
nanoparticles. Toxicol Sci. 77:3–5. 2004.PubMed/NCBI View Article : Google Scholar
|
|
107
|
Lam CW, James JT, McCluskey R and Hunter
RL: Pulmonary toxicity of single-wall carbon nanotubes in mice 7
and 90 days after intratracheal instillation. Toxicol Sci.
77:126–134. 2004.PubMed/NCBI View Article : Google Scholar
|
|
108
|
Stander L and Theodore L: Environmental
implications of nanotechnology - an update. Int J Environ Res
Public Health. 8:470–479. 2011.PubMed/NCBI View Article : Google Scholar
|
|
109
|
Babatunde D, Denwigwe IH, Babatunde OM,
Gbadamosi SL, Babalola IP and Agboola O: Environmental and Societal
Impact of Nanotechnology. IEEE Access. 8:4640–4667. 2020.
|
